Skip to main content
Karyopharm Therapeutics Inc. (KPTIQ)
OTCMKTS · Delayed Price · Currency is USD
0.0254
-0.0001 (-0.39%)
At close: Nov 13, 2026

Karyopharm Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
11358599385486
Market Cap Growth
-99.38%57.91%-13.86%-74.26%-20.76%-57.36%
Enterprise Value
264359220201549595
Last Close Price
0.037.3610.1412.9751.0096.45

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
0.000.920.590.682.452.32
PB Ratio
--0.46-0.46-0.73-23.11-6.10

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
1.802.461.511.383.502.84

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.99-1.04-1.44-2.27-18.72-3.94
Net Debt / Equity Ratio
-0.80-0.83-0.86-0.87-2.03-1.07
Net Debt / EBITDA Ratio
-3.20-2.68-1.34-0.91-0.24-0.87
Net Debt / FCF Ratio
-4.03-3.21-1.25-1.27-0.23-0.79
Asset Turnover
1.361.070.720.490.470.68
Inventory Turnover
0.311.361.541.361.251.01
Quick Ratio
0.710.981.513.165.053.43
Current Ratio
0.791.121.703.375.313.74
Return on Assets (ROA)
-47.61%-41.56%-36.88%-27.05%-26.79%-19.86%
Return on Capital Employed (ROCE)
359.40%-554.60%-165.50%-75.80%-48.70%-42.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-45596.48%-145.47%-89.55%-144.44%-42.94%-25.55%
FCF Yield
-11342.82%-55.93%-149.55%-93.59%-38.88%-22.09%
Buyback Yield / Dilution
-129.56%-29.33%-11.02%-39.54%-8.85%-4.41%